1,406
Participants
Start Date
June 7, 2023
Primary Completion Date
July 1, 2031
Study Completion Date
July 1, 2031
Docetaxel
Docetaxel is a taxoid antineoplastic agent used in the treatment of breast cancer
carboplatin
Carboplatin is a DNA synthesis inhibitor which binds to DNA, inhibits replication and transcription and induces cell death.
Trastuzumab
Trastuzumab is a humanized monoclonal antibody derived from recombinant DNA,
Pertuzumab
Pertuzumab is a recombinant humanized monoclonal antibody that specifically binds to the extracellular dimerization domain (subdomain Ⅱ) of epidermal growth factor receptor 2(HER2).
Epirubicin
Epirubicin is an antineoplastic agent derived from doxorubicin.Epirubicin, like doxorubicin, exerts its antitumor effects by interference with the synthesis and function of DNA and is most active during the S phase of the cell cycle.
cyclophosphamide
An anticancer (antitumor or cytotoxic) chemotherapy drug that is classified as an alkylating agent. Alkylating agents are compounds that prevent the normal connection of the double helix chain by adding an alkyl group to the guanine base of the DNA molecule. It causes breaks in DNA strands, affecting the ability of cancer cells to proliferate.
RECRUITING
Fudan University Shanghai Cancer Center Shanghai, China, 200032, Shanghai
Fudan University
OTHER